Collagenase Clostridium histolyticum in the treatment of Peyronie’s disease: patient selection and perspectives
Paige K Kuhlmann,1 Kenneth J DeLay,2 James Anaissie,2 Wayne JG Hellstrom,2 Faysal A Yafi3 1University of Missouri-Columbia School of Medicine, Columbia, MO, 2Department of Urology, Tulane University School of Medicine, New Orleans, LA, 3Department of Urology, University of California Irvine, Orange...
Main Authors: | Kuhlmann PK, DeLay KJ, Anaissie J, Hellstrom WJG, Yafi FA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-03-01
|
Series: | Patient Preference and Adherence |
Subjects: | |
Online Access: | https://www.dovepress.com/collagenase-clostridium-histolyticum-in-the-treatment-of-peyroniersquo-peer-reviewed-article-PPA |
Similar Items
-
Lateral herniation during treatment with collagenase Clostridium histolyticum (Xiaflex) for Peyronie’s disease
by: Margaret K. Gannon, et al.
Published: (2021-06-01) -
Safety and Efficacy Study of Collagenase Clostridium Histolyticum Applied With an Intensive Protocol in the Treatment of Peyronie's Disease
by: Mª Teresa Melgarejo-Segura, et al.
Published: (2021-06-01) -
The efficacy and safety of intralesional injection of collagenase Clostridium histolyticum for Peyronie’s disease: A meta-analysis of published prospective studies
by: Fuxun Zhang, et al.
Published: (2022-10-01) -
Improvement in the ability to have sex in patients with Peyronie's disease treated with Collagenase Clostridium histolyticum
by: Jeannette P. Geelhoed, et al.
Published: (2023-01-01) -
Treatment Patterns and Healthcare Outcomes with Collagenase Clostridium Histolyticum vs Surgery in Peyronie's Disease: A Retrospective Claims Database Analysis
by: Landon Trost, MD, et al.
Published: (2021-04-01)